Transdermal Delivery Systems for Biomolecules

Purpose The present review article focuses on highlighting the main technologies used as tools that improve the delivery of transdermal biomolecules, addressing them from the point of view of research in the development of transdermal systems that use physical and chemical permeation enhancers and nanocarrier systems or a combination of them. Results Transdermal drug delivery systems have increased in importance since the late 1970s when their use was approved by the Food and Drug Administration (FDA). They appeared to be an alternative resource for the administration of many potent drugs. The first transdermal drug delivery system used for biomolecules was for the treatment of hormonal disorders. Biomolecules have been used primarily in many treatments for cancer and diabetes, vaccines, hormonal disorders, and contraception. Conclusions The latest technologies that have used such transdermal biomolecule transporters include electrical methods (physical penetration enhancers), some chemical penetration enhancers and nanocarriers. All of them allow the maintenance of the physical and chemical properties of the main proteins and peptides through these clinical treatments, allowing their efficient storage, transport, and release and ensuring the achievement of their target and better results in the treatment of many diseases.

Automated summary

Transdermal drug delivery systems have become increasingly important since the late 1970s when approved by the FDA. They are used as an alternative resource for administering potent drugs in treatments like cancer, diabetes, vaccinations, hormonal disorders, and contraception. The latest technologies in transdermal biomolecule transporters include electrical methods, chemical penetration enhancers, and nanocarriers, allowing for efficient storage, transport, and release of proteins and peptides for better treatment outcomes in various diseases.